REGISTRATION RIGHTS AGREEMENT FOR INVESTORSRegistration Rights Agreement • October 11th, 2018 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of March 13, 2018, by and among TFF Pharmaceuticals, Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”.
CONSULTING AGREEMENTConsulting Agreement • October 11th, 2018 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS Consulting Agreement (this “Agreement”), is made by and between TFF Pharmaceuticals, Inc, a Delaware Corporation with its principal place of business at 2801 Via Fortuna, Suite 425, Austin, Texas 78746 (“Company”), and RSM CONSULTING, LLC, a Florida limited liability company having an address of 3980 Deer Crossing Court, Unit 201, Naples, Florida 34114 (“Consultant”). Company and Consultant shall, at times throughout this Agreement, be referred to individually as a “Party” and collectively as the “Parties”.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 11th, 2018 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 13, 2018 (the “Effective Date”), is by and among TFF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers, attached hereto as Exhibit A (individually, a “Buyer” and collectively, the “Buyers”).
Patent License Agreement Agreement No. PM1504101Patent License Agreement • October 11th, 2018 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
This Patent License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).
contribution AND SUBSCRIPTION AGREEMENTContribution and Subscription Agreement • October 11th, 2018 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS CONTRIBUTION AND SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of this 24th day of January, 2018 by and between Lung Therapeutics, Inc., a Texas corporation (the “Contributor”), and TFF Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
